SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001214659-21-001842
Filing Date
2021-02-16
Accepted
2021-02-16 13:03:25
Documents
2

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 m210210sc13ga1.htm SC 13G/A 45490
2 GRAPHIC jdrillick_sig.jpg GRAPHIC 3335
  Complete submission text file 0001214659-21-001842.txt   51908
Mailing Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004
Business Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004 844-511-9056
Larimar Therapeutics, Inc. (Subject) CIK: 0001374690 (see all company filings)

IRS No.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88225 | Film No.: 21635314
SIC: 2834 Pharmaceutical Preparations

Mailing Address 600 THIRD AVENUE 2ND FLOOR NEW YORK NY 10016
Business Address 600 THIRD AVENUE 2ND FLOOR NEW YORK NY 10016 212-601-9786
Sio Capital Management, LLC (Filed by) CIK: 0001482416 (see all company filings)

IRS No.: 204586565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A